Article By:
Zacks Investment Research
Sunday, January 11, 2015 12:42 PM EDT
The worst of the patent cliff is over for the pharma sector which is slowly but steadily recovering from the impact of genericization. The NYSE ARCA Pharmaceutical Index is up 19.3% over the last year.